AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 08/11/19

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with their 2019 Q2 earnings Read more ...

Amneal Pharmaceuticals, Inc. (AMRX) Q2 2019 Results Earnings Conference Call August 05, 2019, 08:30 AM ET Company Participants Mark Donohue - Vice President of Investor Relations and Corporate Communications Chirag Patel - Co-Founder, Co-CEO Chintu Patel - Co-Founder, Co-CEO To...

Amneal Pharmaceuticals ( AMRX ) Q2 results : Revenues: $404.6M (-2.2%). More news on: Amneal Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

IPic Entertainment (NASDAQ: IPIC )  -57%  after bankruptcy filing . More news on: iPic Entertainment Inc., GlycoMimetics, Inc., Cars.com Inc., Stocks on the move, Read more ...

Amneal Pharmaceuticals (NYSE: AMRX ): Q2 Non-GAAP EPS of $0.09 misses by $0.03 ; GAAP EPS of -$0.13 misses by $0.20 . More news on: Amneal Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

‒ Q2 2019 Net Revenue of $405 Million; GAAP Loss per share of $0.13; Combined Adjusted Diluted EPS (1) of $0.09 ‒ ‒ Positive cash flow from operations of $21 million ‒ ‒ Reaffirms Full Year 2019 EBITDA Guidance ‒ ‒ Investor Ca...

Paul Meister Elected Chairman of the Board Investor Call at 8:30 a.m. ET to Discuss Leadership Transition and Second Quarter 2019 Earnings Results Amneal Pharmaceuticals, Inc. (NYSE:AMRX) today announced that its Co-Founders, Chirag Patel and Chintu Patel, have been named Co-Ch...

Alkermes plc ( ALKS +2.9% ) inks an agreement with Amneal Pharmaceuticals LLC ( AMRX +1.6% ) settling the latter's challenge to a U.S. patent covering opioid/alcohol dependence med VIVITROL (naltrexone for extended-release injectable suspension) that expires in 2029. More news on: Al...